Vanguard Growth Index Fund ETF vs Health Care Select Sector SPDR Fund — how do they compare? Vanguard Growth Index Fund ETF trades at $87.74, while Health Care Select Sector SPDR Fund trades at $167.21. Which is the better fit depends on your goals.
| VUG | XLV | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $90.29 | $175.68 |
52-Week Low | $70.00 | $134.13 |
Signals from Pluang's Aura AI — not financial advice
Vanguard Growth ETF (VUG) trades at $88.12, down 0.37% on the day, with a bullish technical signal from moving averages and neutral oscillators. The ETF shows strong institutional buying interest, with multiple advisors increasing positions in Q2 2026, as reported by SEC filings. Recent news highlights performance comparisons with value-oriented peers and emphasizes its low-cost, large-cap growth focus.
The outlook for VUG remains positive given its exposure to growth stocks and institutional accumulation, though risks include market rotation away from growth and concentration in large-cap names. Investors should weigh its low expense ratio and growth potential against broader market volatility and sector-specific headwinds.
XLV trades at $167.16, down 2.5% amid testing key support levels, with technical indicators showing mixed signals between bullish moving averages and bearish oscillators. The healthcare ETF maintains defensive appeal with upcoming dividend payments and sector rotation benefits during potential Fed tightening. Recent options activity shows increased put volume, suggesting some near-term caution among traders.
Healthcare sector strength and defensive positioning support XLV's long-term outlook, though near-term technical weakness and sector-specific headwinds from failed drug trials present risks. The ETF's low expense ratio and diversified healthcare exposure provide stability, with earnings momentum and FDA approvals driving fundamental strength.
Trailing returns across standard periods
Latest headlines on both assets
VUG is an index-based ETF that tracks the CRSP US Large Cap Growth Index, providing concentrated exposure to the largest and fastest-growing companies in the United States. It focuses on stocks with high growth potential across tech, communication, and consumer sectors, serving as a low-cost, high-conviction core holding for long-term capital appreciation.
Read more on VUG →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →